From unpaired and paired BP-CML patient cohorts, we found that FLT3-TAZ signaling was largely absent in CP samples but present in approximately half of the BP-CML samples. Here, FLT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.